The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
How to use high-sensitivity cardiac troponins in acute cardiac care
Abstract
Recommendations for the use of cardiac troponin (cTn) measurement in acute cardiac care have recently been published.1 Subsequently, a high-sensitivity (hs) cTn T assay was introduced into routine clinical practice.2 This assay, as others, called highly sensitive, permits measurement of cTn concentrations in significant numbers of apparently illness-free individuals. These assays can measure cTn in the single digit range of nanograms per litre (=picograms per millilitre) and some research assays even allow detection of concentrations <1 ng/L.2–4 Thus, they provide a more precise calculation of the 99th percentile of cTn concentration in reference subjects (the recommended upper reference limit [URL]). These assays measure the URL with a coefficient of variation (CV) <10%.2–4 The high precision of hs-cTn assays increases their ability to determine small differences in cTn over time. Many assays currently in use have a CV >10% at the 99th percentile URL limiting that ability.5–7 However, the less precise cTn assays do not cause clinically relevant false-positive diagnosis of acute myocardial infarction (AMI) and a CV <20% at the 99th percentile URL is still considered acceptable.8 We believe that hs-cTn assays, if used appropriately, will improve clinical care. We propose criteria for the clinical interpretation of test results based on the limited evidence available at this time. ‘Sensitive’ and ‘high-sensitive’ are terms often used by manufacturers to describe their assays for marketing purposes. In some cases, it reflects higher sensitivity than former assays developed by the same company, and in other situations it reflects a higher sensitivity than most assays on the market. Although there is still no consensus regarding when the terms ‘sensitive’ and ‘high-sensitive’ should be applied, we advocate that cTn assays should be labelled ‘high-sensitive’ only if they fulfil the analytical criteria suggested by guidelines1,9,10 not only in the research laboratories of the manufacturers but also in routine clinical laboratories.11–19 Often manufacturers' claims for assay precision cannot be achieved in clinical laboratories (see Table 1). It is also important to note that there may be substantial differences between ‘high-sensitivity’ assays. Most present cTn assays do not detect even in 50% of apparently disease-free individuals20 whereas high-sensitivity assays do and with some, detection may be as high as in 90%.4,20,21 In addition, reports for the hs-cTnI Singulex®, the hs-cTnT, and the Abbott® hs-cTnI assays suggest a need for different 99th percentile values in men and women, although that does not seem to be the case with the hs-cTnI Beckman® research assay.2,21–24 Peer-reviewed analytical evaluation data on cardiac troponin assays approved for routine diagnostics In addition, hs-cTnI assays fulfilling the analytical criteria of guidelines have been developed by Beckman®, Nanosphere®, Singulex®, and Siemens®, which are still in the pre-marketing phase but may also become available for routine use subsequently. None of the currently commercially available cTn assays except for the hs-cTnT and the yet to be approved hs-cTnI assay from Abbott Diagnostics meets the proposed criteria for a high-sensitivity assay in routine use. It is important to differentiate between the LoB and the LoD, because these terms are frequently not correctly used in the cTn literature. The LoB is the highest signal in a test which can be expected from a sample without the analyte, in contrast the LoD is the lowest concentration of an analyte in a sample which reliably can be differentiated from a sample without the analyte. The LoD is always higher than the LoB. NA, not available; LoB, lower limit of blank; LoD, lower limit of detection. aBench-top systems suitable for point-of-care (POC) analysis but no hand-held POC devices. bNot approved by the US Food and Drug Administration so far. cMay be approved for routine use in Europe in 2012. Peer-reviewed analytical evaluation data on cardiac troponin assays approved for routine diagnostics In addition, hs-cTnI assays fulfilling the analytical criteria of guidelines have been developed by Beckman®, Nanosphere®, Singulex®, and Siemens®, which are still in the pre-marketing phase but may also become available for routine use subsequently. None of the currently commercially available cTn assays except for the hs-cTnT and the yet to be approved hs-cTnI assay from Abbott Diagnostics meets the proposed criteria for a high-sensitivity assay in routine use. It is important to differentiate between the LoB and the LoD, because these terms are frequently not correctly used in the cTn literature. The LoB is the highest signal in a test which can be expected from a sample without the analyte, in contrast the LoD is the lowest concentration of an analyte in a sample which reliably can be differentiated from a sample without the analyte. The LoD is always higher than the LoB. NA, not available; LoB
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Roffi, M., Patrono, C., Collet, J.-P., Mueller, C., Valgimigli, M., Andreotti, F., Bax, J. J., Borger, M. A., Brotons, C., Chew, D. P., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv320 · Cited by 8,261
Self-citationAuthors/Task Force Members, Hamm, C. W., Bassand, J.-P., Agewall, S., Bax, J., Boersma, E., Bueno, H., Caso, P., Dudek, D., Gielen, S., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr236 · Cited by 3,080
Self-citationTask Force Members, Thygesen, K., Alpert, J. S., White, H. D., Biomarker Group, Jaffe, A. S., Apple, F. S., Galvani, M., Katus, H. A., Newby, L. K., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm355 · Cited by 2,541
Self-citationEarly Diagnosis of Myocardial Infarction with Sensitive Cardiac Troponin Assays
Reichlin, T., Hochholzer, W., Bassetti, S., Steuer, S., Stelzig, C., Hartwiger, S., Biedert, S., Schaub, N., Buerge, C., Potocki, M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0900428 · Cited by 1,687
Self-citationSensitive Troponin I Assay in Early Diagnosis of Acute Myocardial Infarction
Keller, T., Zeller, T., Peetz, D., Tzikas, S., Roth, A., Czyz, E., Bickel, C., Baldus, S., Warnholtz, A., Fröhlich, M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0903515 · Cited by 1,150
Self-citationde Lemos, J. A., Drazner, M. H., Omland, T., Ayers, C. R., Khera, A., Rohatgi, A., Hashim, I., Berry, J. D., Das, S. R., Morrow, D. A., et al. (2010) · JAMA · doi:10.1001/jama.2010.1768 · Cited by 1,102
Analytical Validation of a High-Sensitivity Cardiac Troponin T Assay
Giannitsis, E., Kurz, K., Hallermayer, K., Jarausch, J., Jaffe, A. S., & Katus, H. A. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2009.132654 · Cited by 1,084
Self-citationA Sensitive Cardiac Troponin T Assay in Stable Coronary Artery Disease
Omland, T., de Lemos, J. A., Sabatine, M. S., Christophi, C. A., Rice, M. M., Jablonski, K. A., Tjora, S., Domanski, M. J., Gersh, B. J., Rouleau, J. L., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0805299 · Cited by 901
Analytical Characteristics of High-Sensitivity Cardiac Troponin Assays
Apple, F. S., Collinson, P. O., & for the IFCC Task Force on Clinical Applications of Cardiac Biomarkers (2012) · Clinical Chemistry · doi:10.1373/clinchem.2011.165795 · Cited by 861
Self-citationSaunders, J. T., Nambi, V., de Lemos, J. A., Chambless, L. E., Virani, S. S., Boerwinkle, E., Hoogeveen, R. C., Liu, X., Astor, B. C., Mosley, T. H., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.005264 · Cited by 755
Cited by
Roffi, M., Patrono, C., Collet, J.-P., Mueller, C., Valgimigli, M., Andreotti, F., Bax, J. J., Borger, M. A., Brotons, C., Chew, D. P., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv320 · Cited by 8,261
Self-citationFourth universal definition of myocardial infarction (2018)
Thygesen, K., Alpert, J. S., Jaffe, A. S., Chaitman, B. R., Bax, J. J., Morrow, D. A., White, H. D., ESC Scientific Document Group, Thygesen, K., Alpert, J. S., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehy462 · Cited by 5,880
Self-citation2023 ESC Guidelines for the management of acute coronary syndromes
Byrne, R. A., Rossello, X., Coughlan, J. J., Barbato, E., Berry, C., Chieffo, A., Claeys, M. J., Dan, G.-A., Dweck, M. R., Galbraith, M., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad191 · Cited by 5,333
Self-citationCollet, J.-P., Thiele, H., Barbato, E., Barthélémy, O., Bauersachs, J., Bhatt, D. L., Dendale, P., Dorobantu, M., Edvardsen, T., Folliguet, T., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehaa575 · Cited by 5,037
Self-citationFourth Universal Definition of Myocardial Infarction (2018)
Thygesen, K., Alpert, J. S., Jaffe, A. S., Chaitman, B. R., Bax, J. J., Morrow, D. A., & White, H. D. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.08.1038 · Cited by 4,118
Self-citationFourth Universal Definition of Myocardial Infarction (2018)
Thygesen, K., Alpert, J. S., Jaffe, A. S., Chaitman, B. R., Bax, J. J., Morrow, D. A., White, H. D., & The Executive Group on behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction (2018) · Circulation · doi:10.1161/cir.0000000000000617 · Cited by 3,799
Self-citation2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
Amsterdam, E. A., Wenger, N. K., Brindis, R. G., Casey, D. E., Ganiats, T. G., Holmes, D. R., Jaffe, A. S., Jneid, H., Kelly, R. F., Kontos, M. C., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.09.017 · Cited by 3,595
Self-citationThird universal definition of myocardial infarction
Thygesen, K., Alpert, J. S., Jaffe, A. S., Simoons, M. L., Chaitman, B. R., White, H. D., the Writing Group on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction, Authors/Task Force Members Chairpersons, Thygesen, K., Alpert, J. S., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs184 · Cited by 3,058
Self-citationThird Universal Definition of Myocardial Infarction
Thygesen, K., Alpert, J. S., Jaffe, A. S., Simoons, M. L., Chaitman, B. R., & White, H. D. (2012) · Circulation · doi:10.1161/cir.0b013e31826e1058 · Cited by 2,985
Self-citationThird Universal Definition of Myocardial Infarction
Thygesen, K., Alpert, J. S., Jaffe, A. S., Simoons, M. L., Chaitman, B. R., White, H. D., Thygesen, K., Alpert, J. S., White, H. D., Jaffe, A. S., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.08.001 · Cited by 2,621
Self-citationThird universal definition of myocardial infarction
the Writing Group on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction, Thygesen, K., Alpert, J. S., Jaffe, A. S., Simoons, M. L., Chaitman, B. R., & White, H. D. (2012) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2012.122 · Cited by 2,053
Self-citationGulati, M., Levy, P. D., Mukherjee, D., Amsterdam, E., Bhatt, D. L., Birtcher, K. K., Blankstein, R., Boyd, J., Bullock-Palmer, R. P., Conejo, T., et al. (2021) · Circulation · doi:10.1161/cir.0000000000001029 · Cited by 1,611
Amsterdam, E. A., Wenger, N. K., Brindis, R. G., Casey, D. E., Ganiats, T. G., Holmes, D. R., Jaffe, A. S., Jneid, H., Kelly, R. F., Kontos, M. C., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000134 · Cited by 1,059
Self-citation2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain
Gulati, M., Levy, P. D., Mukherjee, D., Amsterdam, E., Bhatt, D. L., Birtcher, K. K., Blankstein, R., Boyd, J., Bullock-Palmer, R. P., Conejo, T., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.07.053 · Cited by 824
JCS 2018 Guideline on Diagnosis and Treatment of Acute Coronary Syndrome
Kimura, K., Kimura, T., Ishihara, M., Nakagawa, Y., Nakao, K., Miyauchi, K., Sakamoto, T., Tsujita, K., Hagiwara, N., Miyazaki, S., et al. (2019) · Circulation Journal · doi:10.1253/circj.cj-19-0133 · Cited by 565
Third Universal Definition of Myocardial Infarction
Thygesen, K., Alpert, J. S., Jaffe, A. S., Simoons, M. L., Chaitman, B. R., White, H. D., & For the Universal Definition of MI, W. G. J. E. (2012) · Global Heart · doi:10.1016/j.gheart.2012.08.001 · Cited by 544
Self-citationFourth Universal Definition of Myocardial Infarction (2018)
Thygesen, K., Alpert, J. S., Jaffe, A. S., Chaitman, B. R., Bax, J. J., Morrow, D. A., & White, H. D. (2018) · Global Heart · doi:10.1016/j.gheart.2018.08.004 · Cited by 460
Self-citationWu, A. H. B., Christenson, R. H., Greene, D. N., Jaffe, A. S., Kavsak, P. A., Ordonez-Llanos, J., & Apple, F. S. (2018) · Clinical Chemistry · doi:10.1373/clinchem.2017.277186 · Cited by 450
Self-citationMetra, M., Cotter, G., Davison, B. A., Felker, G. M., Filippatos, G., Greenberg, B. H., Ponikowski, P., Unemori, E., Voors, A. A., Adams, K. F., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.11.005 · Cited by 427
ST-segment elevation myocardial infarction
Vogel, B., Claessen, B. E., Arnold, S. V., Chan, D., Cohen, D. J., Giannitsis, E., Gibson, C. M., Goto, S., Katus, H. A., Kerneis, M., et al. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0090-3 · Cited by 419
Self-citation(2015) · doi:10.1002/ejhf.289 · Cited by 417
Self-citationApple, F. S., Sandoval, Y., Jaffe, A. S., & Ordonez-Llanos, J. (2017) · Clinical Chemistry · doi:10.1373/clinchem.2016.255109 · Cited by 408
Self-citationDeFilippis, A. P., Chapman, A. R., Mills, N. L., de Lemos, J. A., Arbab-Zadeh, A., Newby, L. K., & Morrow, D. A. (2019) · Circulation · doi:10.1161/circulationaha.119.040631 · Cited by 387
Age- and Sex-Dependent Upper Reference Limits for the High-Sensitivity Cardiac Troponin T Assay
Gore, M. O., Seliger, S. L., deFilippi, C. R., Nambi, V., Christenson, R. H., Hashim, I. A., Hoogeveen, R. C., Ayers, C. R., Sun, W., McGuire, D. K., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.12.032 · Cited by 370
Mueller, C., Giannitsis, E., Christ, M., Ordóñez-Llanos, J., deFilippi, C., McCord, J., Body, R., Panteghini, M., Jernberg, T., Plebani, M., et al. (2016) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2015.11.013 · Cited by 358
Self-citationApplication of High-Sensitivity Troponin in Suspected Myocardial Infarction
Neumann, J. T., Twerenbold, R., Ojeda, F., Sörensen, N. A., Chapman, A. R., Shah, A. S. V., Anand, A., Boeddinghaus, J., Nestelberger, T., Badertscher, P., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1803377 · Cited by 346
Self-citationCardiac biomarkers of acute coronary syndrome: from history to high-sensitivity cardiac troponin
Garg, P., Morris, P., Fazlanie, A. L., Vijayan, S., Dancso, B., Dastidar, A. G., Plein, S., Mueller, C., & Haaf, P. (2017) · Internal and Emergency Medicine · doi:10.1007/s11739-017-1612-1 · Cited by 319
Self-citationCullen, L., Mueller, C., Parsonage, W. A., Wildi, K., Greenslade, J. H., Twerenbold, R., Aldous, S., Meller, B., Tate, J. R., Reichlin, T., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.078 · Cited by 317
Self-citation2023 ESC Guidelines for the management of acute coronary syndromes
Byrne, R. A., Rossello, X., Coughlan, J. J., Barbato, E., Berry, C., Chieffo, A., Claeys, M. J., Dan, G.-A., Dweck, M. R., Galbraith, M., et al. (2024) · European Heart Journal: Acute Cardiovascular Care · doi:10.1093/ehjacc/zuad107 · Cited by 314
Self-citationApple, F. S., Jaffe, A. S., Collinson, P., Mockel, M., Ordonez-Llanos, J., Lindahl, B., Hollander, J., Plebani, M., Than, M., & Chan, M. H. M. (2015) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2014.08.021 · Cited by 286
Self-citationClinical Use of High-Sensitivity Cardiac Troponin in Patients With Suspected Myocardial Infarction
Twerenbold, R., Boeddinghaus, J., Nestelberger, T., Wildi, K., Rubini Gimenez, M., Badertscher, P., & Mueller, C. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.07.718 · Cited by 255
Self-citationAssessment and classification of patients with myocardial injury and infarction in clinical practice
Chapman, A. R., Adamson, P. D., & Mills, N. L. (2017) · Heart · doi:10.1136/heartjnl-2016-309530 · Cited by 253
High-sensitivity assays for troponin in patients with cardiac disease
Westermann, D., Neumann, J. T., Sörensen, N. A., & Blankenberg, S. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.48 · Cited by 222
Self-citationDiaz-Garzon, J., Fernandez-Calle, P., Sandberg, S., Özcürümez, M., Bartlett, W. A., Coskun, A., Carobene, A., Perich, C., Simon, M., Marques, F., et al. (2021) · Clinical Chemistry · doi:10.1093/clinchem/hvaa261 · Cited by 42
Metadata
- Authors
- Thygesen, K., Mair, J., Giannitsis, E., Mueller, C., Lindahl, B., Blankenberg, S., Huber, K., Plebani, M., Biasucci, L. M., Tubaro, M., Collinson, P., Venge, P., Hasin, Y., Galvani, M., Koenig, W., Hamm, C., Alpert, J. S., Katus, H., Jaffe, A. S., & the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-06-21
- Volume
- 33
- Issue
- 18
- Pages
- 2252-2257
- ISSN
- 0195-668X (ISSN-L)
- 1522-9645
- OpenAlex
- W2139243268
- Cited by
- 784
- References
- 46
- FWCI
- 44.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.